Developer docs
API playgroundTry for free, no card

Search company profiles

Bioteck

Full company profile

uuid000lyra

Namestring
Bioteck
Legal namestring
BIOTECK S.p.A.
Websiteurl
bioteck.com
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Bioteck S.p.A. is a privately held Italian medical device manufacturer founded in 1995 and headquartered in Arcugnano (Vicenza), with its primary R&D and production operations at a 2,000+ square-meter multifunctional facility in Riva presso Chieri (Turin) that includes 250 square meters of clean rooms. The company designs, develops, and produces biological tissue substitutes for regenerative surgery across three medical specialties: dentistry (periodontal, peri-implant, and bone-regeneration applications), orthopedics (cartilage and bone regeneration, joint infiltration), and neurosurgery (spinal and dural procedures). Its core technology is Zymo-Teck®, a patented enzymatic deantigenation process (UIBM no. 0001413858) that makes equine-derived bone and pericardium tissue biocompatible without chemical solvents or high temperatures, followed by beta-ray sterilization; this platform underlies the company's 15+ branded products including Heart®, MeRG®, Flex Cortical Sheet, H42®, CHondroGrid®, Osteoxenon®, Bio-Gen®, Calcitos®, Xenomatrix®, Activabone®, Angiostad®, and Synt®.

Bioteck generates revenue exclusively through direct sales and a network of qualified distribution partners operating in over 70 countries, selling to a long-tail base of healthcare professionals (surgeons, dentists, periodontists, hospitals). Pricing is not publicly disclosed and is handled through commercial inquiry. The company is ISO 13485:2016 certified (through 2028), holds ANVISA certification for Brazil, and is pursuing FDA and CFDA clearances for US and China entry. Cumulative operating scale includes 2,000,000+ pieces used in regenerative interventions, 500+ clinical scientific publications, and 2,000+ surgeries documented in peer-reviewed literature with follow-up to 13 years, supporting clinical-evidence-based marketing through the Bioteck Academy training platform and active participation in major industry congresses (EAO, IDS, ESSKA, EUROPERIO). Recent product launches — H42® (2023), Flex Cortical Sheet (2024), CHondroGrid® (2025), and Heart®/MeRG® (2026) — indicate ongoing portfolio expansion into adjacent regenerative-medicine categories.

Short descriptiontext

Bioteck is an Italian privately held medical device manufacturer (founded 1995) that designs and produces equine-derived tissue substitutes for regenerative dentistry, orthopedics, and neurosurgery, sold through distribution partners in 70+ countries. Its proprietary Zymo-Teck® enzymatic process underpins 15+ branded products including bone grafts, membranes, and hydrogels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersArcugnano, Italy
HQ citystring
Arcugnano
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bone graft substitutes, regenerative medicine devices, collagen membranes, equine tissue grafts, dental biomaterials
Industry5 codes
PRIMARYHLAAAGAB
Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAHAEAG
Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLABACAI
Periodontal Regeneration (GTR/EMD/Biologics)
Healthcare & Life Sciences/Dental Care Services/Periodontics (Gum & Implant Services)
SECONDARYHLAAAGAL
Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Biological Products, (No Disgnostic Substances)2836
Product category
Regenerative Medicine Medical Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Devices Sales
TypeHardware Sales
Description

Bioteck generates revenue through the sale of biological medical devices including bone grafts, collagen membranes, hydrogels, and other tissue substitutes for regenerative surgery applications in dentistry, orthopedics, and neurosurgery.

Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 16 records shown
1Heart®
Description

Biological membrane obtained from equine pericardium for bone regeneration surgical procedures

+15 more records
Core offering1 text field

Bioteck designs, develops, and manufactures biological and synthetic tissue substitutes — including bone grafts, collagen membranes, hydrogels, bone pastes, and an infiltrative collagen device — for regenerative surgery in dentistry, orthopedics, and neurosurgery. Products are produced from equine-derived tissues processed through the company's proprietary Zymo-Teck® enzymatic deantigenation technology and sold under multiple branded lines.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 500+ clinical scientific publications support product efficacy
+2 more records
Product overview1 text field

Bioteck is a medical device manufacturer specializing in regenerative medicine and tissue substitutes since 1995. The company operates as a portfolio of distinct product lines across three medical specialties: Dentistry (periodontal treatments, bone grafts, membranes), Orthopedics (bone pastes, cartilage regeneration, joint treatments), and Neurosurgery (spine and dural substitutes). The core technology platform is Zymo-Teck®, a proprietary enzymatic deantigenation process that makes equine-derived tissues biocompatible while preserving collagen and mineral components. Key products include: H42® collagen hydrogel for periodontal pockets; Flex Cortical Sheet flexible bone sheets; Heart® pericardium membrane; MeRG® collagen membrane for cartilage defects; Bio-Gen® hydrolyzed collagen bone graft; Osteoxenon® preserved collagen bone graft; CHondroGrid® hydrolyzed collagen for joint injection; plus synthetic lines (Synt® beta-TCP) and bone pastes (Activabone®, Angiostad®). Products are sold in over 70 countries worldwide.

Product and service15 records
1H42® Collagen Hydrogel
CategoryDental Biomaterials
Description

Innovative collagen-based hydrogel in syringe for the non-surgical treatment of periodontal and peri-implant pockets. Extruded via luer-lock syringe with compatible needles (Gauge 20-27). Targets dental professionals treating periodontal disease.

2Flex Cortical Sheet
CategoryBone Graft Substitutes
Description

Flexible cortical bone sheets derived from equine bone via Zymo-Teck® enzymatic deantigenation. Becomes flexible upon hydration in saline solution. Sizes 21-25 x 23-27 mm, available in 3 thicknesses for periodontal/peri-implant, horizontal GBR/alveolar preservation, and complex GBR applications. Acts as barrier for up to 6 months.

3Heart® Pericardium Membrane
CategoryBiological Membranes
Description

Biological membrane obtained from authentic equine pericardium with multi-layer structure and identical surfaces on both sides. Provides bone graft protection for 3-4 months while acting as substrate for tissue regeneration. Suitable for GBR/GTR procedures in dentistry, orthopedics and neurosurgery.

4MeRG® Collagen Membrane
CategoryBiological Membranes
Description

Double-layer collagen membrane (type I from equine tendon) for guided regeneration of osteochondral defects. Used with bone marrow stimulation techniques (microfractures). For Grade III-IV cartilage lesions with subchondral bone involvement, defect size >2cm², depth 5-6mm.

5Osteoxenon® Bone Graft
CategoryBone Graft Substitutes
Description

Heterologous bone graft with preserved collagen. Enzymatic deantigenation via Zymo-Teck® process preserves bone collagen and mineral component. Enables total remodeling with patient's bone.

6Bio-Gen® Bone Graft
CategoryBone Graft Substitutes
Description

Hydrolyzed collagen heterologous bone graft. Natural, biocompatible and osteoconductive scaffold for complete bone remodeling.

7CHondroGrid® Infiltrative Device
CategoryOrthopedic Injectables
Description

Infiltrative device made of hydrolyzed collagen for pain relief and functional recovery of major joints and musculo-tendineous-ligamentous structures.

8Calcitos® Bone Substitute
CategoryBone Graft Substitutes
Description

Slow-absorbing equine bone substitute obtained by heat treatment. Long-lasting bone substitute for regenerative procedures.

9Osteoplant® Spine
CategoryNeurosurgery Products
Description

Biological bone graft for spine surgery with total biocompatibility, ideal osteoconduction, and complete remodeling.

10Heart® DM Dural Matrix
CategoryNeurosurgery Products
Description

Biological matrix for dural replacement in neurosurgery.

11Xenomatrix® Collagen Matrix
CategoryBiological Membranes
Description

Three-dimensional collagen matrix for guided tissue regeneration.

12Synt® Synthetic Bone Graft
CategorySynthetic Bone Substitutes
Description

Synthetic bone graft line based on beta-tricalcium phosphate for regenerative surgery.

13Activabone® Bone Paste
CategoryBone Graft Substitutes
Description

New generation visco-modulated bone pastes for orthopedic applications.

14Angiostad® Bone Paste
CategoryBone Graft Substitutes
Description

Biocompatible and osteopromotive bone pastes for bone regeneration in orthopedics.

15Awayr® Perfusion System
CategorySurgical Accessories
Description

Perfusion system capable of saturating any type of porous biomaterial with biological fluids or solutions, addressing the risk of air remaining in traditionally soaked biomaterials.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-01-01
Description

Bioteck collaborated with Laboratorios Normon at the XX SECIB Congress in Spain (2023) for the distribution and promotion of products in the Spanish market.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2013-01-01
Description

Bioteck maintains a network of qualified and prestigious commercial partners in over 70 countries who handle local sales, distribution, and customer support for Bioteck medical devices.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swiss-headquartered leader in dental bone regeneration and collagen membranes (Bio-Oss®, Bio-Gide®). Highly comparable to Bioteck in serving dental/oral surgeons with xenogeneic and collagen-based regenerative materials in the same GBR/periodontal use cases.

TypeDirect peer
Description

US-listed regenerative medicine specialist in dural repair (DuraGen®), neurosurgery, and orthopedic soft tissue. Directly comparable to Bioteck's Heart® DM dural membrane and Osteoplant® Spine portfolio, with overlap in neurosurgery and regenerative biologics.

3RTI Surgical
TypeDirect peer
Description

Tissue-based implant manufacturer producing allograft and xenograft bone grafts, sports medicine, and surgical specialties. Comparable to Bioteck in selling tissue-derived regenerative materials across orthopedics, dental, and surgical channels.

TypeDirect peer
Description

Non-profit tissue banking organization providing allograft bone grafts, dermal matrices, and cardiac/orthopedic tissue implants. Comparable to Bioteck in processing biological tissue into regenerative surgical products, though primarily human-derived rather than equine.

5botiss biomaterials
TypeDirect peer
Description

German dental regeneration specialist offering bone grafts (cerabone®, maxgraft®), collagen membranes (Jason®), and soft-tissue substitutes for GBR and periodontal applications. Closely comparable niche competitor to Bioteck's dental product lines.

TypeBroad incumbent
Description

Global orthopedic and surgical medtech incumbent with broad regenerative medicine and biologics offerings. Comparable as a large established player overlapping Bioteck in orthopedic bone graft substitutes and surgical implants, but with vastly broader product portfolio.

TypeBroad incumbent
Description

Largest medical device company globally with significant spine, neurosurgery, and biologics businesses (INFUSE® bone graft). Comparable in serving the same spine and neurosurgery customers as Bioteck's Osteoplant® Spine and Heart® DM, but at massive scale.

TypeBroad incumbent
Description

Orthopedic and neurosurgery franchise of J&J offering trauma, spine, sports medicine, and biologics. Comparable to Bioteck in orthopedic and neurosurgical regenerative materials, but as part of a multi-billion-dollar diversified medtech portfolio.

TypeBroad incumbent
Description

Global orthopedic reconstructive and surgical devices leader with regenerative and biologic offerings. Overlaps with Bioteck in orthopedic bone graft substitutes and sports medicine regenerative products.

TypeDirect peer
Description

US-based manufacturer of synthetic bone graft substitutes (calcium phosphosilicate-based NovaBone®) sold across dental, orthopedic, and trauma channels. Comparable niche peer to Bioteck in delivering regenerative bone graft materials to dental and orthopedic surgeons, with a primarily synthetic focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioteck

Regenerative Medicine Medical Devicesbioteck.com

Bioteck is an Italian privately held medical device manufacturer (founded 1995) that designs and produces equine-derived tissue substitutes for regenerative dentistry, orthopedics, and neurosurgery, sold through distribution partners in 70+ countries. Its proprietary Zymo-Teck® enzymatic process underpins 15+ branded products including bone grafts, membranes, and hydrogels.

What Bioteck does

Bioteck S.p.A. is a privately held Italian medical device manufacturer founded in 1995 and headquartered in Arcugnano (Vicenza), with its primary R&D and production operations at a 2,000+ square-meter multifunctional facility in Riva presso Chieri (Turin) that includes 250 square meters of clean rooms. The company designs, develops, and produces biological tissue substitutes for regenerative surgery across three medical specialties: dentistry (periodontal, peri-implant, and bone-regeneration applications), orthopedics (cartilage and bone regeneration, joint infiltration), and neurosurgery (spinal and dural procedures). Its core technology is Zymo-Teck®, a patented enzymatic deantigenation process (UIBM no. 0001413858) that makes equine-derived bone and pericardium tissue biocompatible without chemical solvents or high temperatures, followed by beta-ray sterilization; this platform underlies the company's 15+ branded products including Heart®, MeRG®, Flex Cortical Sheet, H42®, CHondroGrid®, Osteoxenon®, Bio-Gen®, Calcitos®, Xenomatrix®, Activabone®, Angiostad®, and Synt®.

Bioteck generates revenue exclusively through direct sales and a network of qualified distribution partners operating in over 70 countries, selling to a long-tail base of healthcare professionals (surgeons, dentists, periodontists, hospitals). Pricing is not publicly disclosed and is handled through commercial inquiry. The company is ISO 13485:2016 certified (through 2028), holds ANVISA certification for Brazil, and is pursuing FDA and CFDA clearances for US and China entry. Cumulative operating scale includes 2,000,000+ pieces used in regenerative interventions, 500+ clinical scientific publications, and 2,000+ surgeries documented in peer-reviewed literature with follow-up to 13 years, supporting clinical-evidence-based marketing through the Bioteck Academy training platform and active participation in major industry congresses (EAO, IDS, ESSKA, EUROPERIO). Recent product launches — H42® (2023), Flex Cortical Sheet (2024), CHondroGrid® (2025), and Heart®/MeRG® (2026) — indicate ongoing portfolio expansion into adjacent regenerative-medicine categories.

Bioteck firmographics

Firmographics
Name
Bioteck
Legal name
BIOTECK S.p.A.
Website
https://bioteck.com
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
11–50 employees
Short description
Bioteck is an Italian privately held medical device manufacturer (founded 1995) that designs and produces equine-derived tissue substitutes for regenerative dentistry, orthopedics, and neurosurgery, sold through distribution partners in 70+ countries. Its proprietary Zymo-Teck® enzymatic process underpins 15+ branded products including bone grafts, membranes, and hydrogels.
Ownership category
akta.pro rank

Bioteck industry classification

Industry
Product category
Regenerative Medicine Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAGAB
Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAHAEAG
Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLABACAI
Periodontal Regeneration (GTR/EMD/Biologics)
Healthcare & Life Sciences/Dental Care Services/Periodontics (Gum & Implant Services)
SECONDARYHLAAAGAL
Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

  • Bone graft substitutes
  • Regenerative medicine devices
  • Collagen membranes
  • Equine tissue grafts
  • Dental biomaterials

Where Bioteck is headquartered

Location

Headquarters

HQ city
Arcugnano
HQ country
Italy
HQ region
Europe

Offices2 records

Markets served

Bioteck business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

Revenue model

  1. Medical Devices Sales: Bioteck generates revenue through the sale of biological medical devices including bone grafts, collagen membranes, hydrogels, and other tissue substitutes for regenerative surgery applications in dentistry, orthopedics, and neurosurgery.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Bioteck product offering

Product offering

Core offering

Bioteck designs, develops, and manufactures biological and synthetic tissue substitutes — including bone grafts, collagen membranes, hydrogels, bone pastes, and an infiltrative collagen device — for regenerative surgery in dentistry, orthopedics, and neurosurgery. Products are produced from equine-derived tissues processed through the company's proprietary Zymo-Teck® enzymatic deantigenation technology and sold under multiple branded lines.

Product overview

Bioteck is a medical device manufacturer specializing in regenerative medicine and tissue substitutes since 1995. The company operates as a portfolio of distinct product lines across three medical specialties: Dentistry (periodontal treatments, bone grafts, membranes), Orthopedics (bone pastes, cartilage regeneration, joint treatments), and Neurosurgery (spine and dural substitutes). The core technology platform is Zymo-Teck®, a proprietary enzymatic deantigenation process that makes equine-derived tissues biocompatible while preserving collagen and mineral components. Key products include: H42® collagen hydrogel for periodontal pockets; Flex Cortical Sheet flexible bone sheets; Heart® pericardium membrane; MeRG® collagen membrane for cartilage defects; Bio-Gen® hydrolyzed collagen bone graft; Osteoxenon® preserved collagen bone graft; CHondroGrid® hydrolyzed collagen for joint injection; plus synthetic lines (Synt® beta-TCP) and bone pastes (Activabone®, Angiostad®). Products are sold in over 70 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • Heart®: Biological membrane obtained from equine pericardium for bone regeneration surgical procedures
  • MeRG®
  • H42®
  • Osteoxenon®
  • Bio-Gen®
  • Flex Cortical Sheet
  • CHondroGrid®
  • Calcitos®
  • Xenomatrix®
  • Awayr®
  • Synt®
  • Zymo-Teck®
  • Osteoplant® Spine
  • Heart® DM
  • Activabone®
  • Bioteck Academy

Products and services

  • H42® Collagen Hydrogel Innovative collagen-based hydrogel in syringe for the non-surgical treatment of periodontal and peri-implant pockets. Extruded via luer-lock syringe with compatible needles (Gauge 20-27). Targets dental professionals treating periodontal disease.
  • Flex Cortical Sheet Flexible cortical bone sheets derived from equine bone via Zymo-Teck® enzymatic deantigenation. Becomes flexible upon hydration in saline solution. Sizes 21-25 x 23-27 mm, available in 3 thicknesses for periodontal/peri-implant, horizontal GBR/alveolar preservation, and complex GBR applications. Acts as barrier for up to 6 months.
  • Heart® Pericardium Membrane Biological membrane obtained from authentic equine pericardium with multi-layer structure and identical surfaces on both sides. Provides bone graft protection for 3-4 months while acting as substrate for tissue regeneration. Suitable for GBR/GTR procedures in dentistry, orthopedics and neurosurgery.
  • MeRG® Collagen Membrane Double-layer collagen membrane (type I from equine tendon) for guided regeneration of osteochondral defects. Used with bone marrow stimulation techniques (microfractures). For Grade III-IV cartilage lesions with subchondral bone involvement, defect size >2cm², depth 5-6mm.
  • Osteoxenon® Bone Graft Heterologous bone graft with preserved collagen. Enzymatic deantigenation via Zymo-Teck® process preserves bone collagen and mineral component. Enables total remodeling with patient's bone.
  • Bio-Gen® Bone Graft Hydrolyzed collagen heterologous bone graft. Natural, biocompatible and osteoconductive scaffold for complete bone remodeling.
  • CHondroGrid® Infiltrative Device Infiltrative device made of hydrolyzed collagen for pain relief and functional recovery of major joints and musculo-tendineous-ligamentous structures.
  • Calcitos® Bone Substitute Slow-absorbing equine bone substitute obtained by heat treatment. Long-lasting bone substitute for regenerative procedures.
  • Osteoplant® Spine Biological bone graft for spine surgery with total biocompatibility, ideal osteoconduction, and complete remodeling.
  • Heart® DM Dural Matrix Biological matrix for dural replacement in neurosurgery.
  • Xenomatrix® Collagen Matrix Three-dimensional collagen matrix for guided tissue regeneration.
  • Synt® Synthetic Bone Graft Synthetic bone graft line based on beta-tricalcium phosphate for regenerative surgery.
  • Activabone® Bone Paste New generation visco-modulated bone pastes for orthopedic applications.
  • Angiostad® Bone Paste Biocompatible and osteopromotive bone pastes for bone regeneration in orthopedics.
  • Awayr® Perfusion System Perfusion system capable of saturating any type of porous biomaterial with biological fluids or solutions, addressing the risk of air remaining in traditionally soaked biomaterials.

Quantifiable outcome

  • 500+ clinical scientific publications support product efficacy
  • +2 more outcomes

Companies that use Bioteck

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Bioteck technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Bioteck partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor and core.

  • Laboratorios NormonminorChannel Partner/ Reseller/ Distributor · 1 January 2023Bioteck collaborated with Laboratorios Normon at the XX SECIB Congress in Spain (2023) for the distribution and promotion of products in the Spanish market.
  • Qualified Commercial Partners (70+ countries)coreChannel Partner/ Reseller/ Distributor · 1 January 2013Bioteck maintains a network of qualified and prestigious commercial partners in over 70 countries who handle local sales, distribution, and customer support for Bioteck medical devices.

Scale indicators5 records

Recent moves10 records

Expansion highlights4 records

Bioteck competitors and assessment

Company assessment

Direct peers

  • Geistlich Pharma: Swiss-headquartered leader in dental bone regeneration and collagen membranes (Bio-Oss®, Bio-Gide®). Highly comparable to Bioteck in serving dental/oral surgeons with xenogeneic and collagen-based regenerative materials in the same GBR/periodontal use cases.
  • Integra LifeSciences: US-listed regenerative medicine specialist in dural repair (DuraGen®), neurosurgery, and orthopedic soft tissue. Directly comparable to Bioteck's Heart® DM dural membrane and Osteoplant® Spine portfolio, with overlap in neurosurgery and regenerative biologics.
  • RTI Surgical: Tissue-based implant manufacturer producing allograft and xenograft bone grafts, sports medicine, and surgical specialties. Comparable to Bioteck in selling tissue-derived regenerative materials across orthopedics, dental, and surgical channels.
  • LifeNet Health: Non-profit tissue banking organization providing allograft bone grafts, dermal matrices, and cardiac/orthopedic tissue implants. Comparable to Bioteck in processing biological tissue into regenerative surgical products, though primarily human-derived rather than equine.
  • botiss biomaterials: German dental regeneration specialist offering bone grafts (cerabone®, maxgraft®), collagen membranes (Jason®), and soft-tissue substitutes for GBR and periodontal applications. Closely comparable niche competitor to Bioteck's dental product lines.
  • NovaBone Products: US-based manufacturer of synthetic bone graft substitutes (calcium phosphosilicate-based NovaBone®) sold across dental, orthopedic, and trauma channels. Comparable niche peer to Bioteck in delivering regenerative bone graft materials to dental and orthopedic surgeons, with a primarily synthetic focus.

Broad incumbents

  • Stryker: Global orthopedic and surgical medtech incumbent with broad regenerative medicine and biologics offerings. Comparable as a large established player overlapping Bioteck in orthopedic bone graft substitutes and surgical implants, but with vastly broader product portfolio.
  • Medtronic: Largest medical device company globally with significant spine, neurosurgery, and biologics businesses (INFUSE® bone graft). Comparable in serving the same spine and neurosurgery customers as Bioteck's Osteoplant® Spine and Heart® DM, but at massive scale.
  • Johnson & Johnson (DePuy Synthes): Orthopedic and neurosurgery franchise of J&J offering trauma, spine, sports medicine, and biologics. Comparable to Bioteck in orthopedic and neurosurgical regenerative materials, but as part of a multi-billion-dollar diversified medtech portfolio.
  • Zimmer Biomet: Global orthopedic reconstructive and surgical devices leader with regenerative and biologic offerings. Overlaps with Bioteck in orthopedic bone graft substitutes and sports medicine regenerative products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Bioteck social profiles

Digital presence

Bioteck compliance and trust

Trust signal

Compliance3 records

Bioteck financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioteck leadership team

Management profile

Number of profiles

Bioteck funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioteck M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioteck

What does Bioteck do?

Bioteck designs, develops, and manufactures biological and synthetic tissue substitutes — including bone grafts, collagen membranes, hydrogels, bone pastes, and an infiltrative collagen device — for regenerative surgery in dentistry, orthopedics, and neurosurgery. Products are produced from equine-derived tissues processed through the company's proprietary Zymo-Teck® enzymatic deantigenation technology and sold under multiple branded lines.

Is Bioteck a public or private company?

Bioteck is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Bioteck founded?

Bioteck was founded in 1995. It employs 11 to 50 people.

Where is Bioteck based?

Bioteck is headquartered in Arcugnano, Italy, in the Europe region.

How does Bioteck make money?

One revenue line is on record: medical Devices Sales.

Who are Bioteck's main competitors?

Direct peers on record are Geistlich Pharma, Integra LifeSciences, RTI Surgical, LifeNet Health, botiss biomaterials and NovaBone Products. Broad incumbents are Stryker, Medtronic, Johnson & Johnson (DePuy Synthes) and Zimmer Biomet.

Does Bioteck have an API?

No public API is recorded for Bioteck.

What industry is Bioteck in?

Bioteck's product category is Regenerative Medicine Medical Devices. Its primary akta.pro industry code is HLAAAGAB, Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales